Edwards Lifesciences Officer Files Intent to Sell $169K in Stock
Edwards Lifesciences Corp
Subscribe to track EW
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Edwards Lifesciences Officer Files Intent to Sell $169K in Stock
Company: Edwards Lifesciences Corp (EW) Form: 144 | Filed: 2025-12-11 Significance: Low
Insider: Chopra Daveen Title: Officer
Transaction: • Type: Proposed Sale • Shares: 2,000 • Value: ~$168,750 • Price: ~$84.38
Key Insight: An officer has filed a notice of a proposed sale for a small amount of stock, representing a negligible fraction of the company's market capitalization and public float.
Market Context: This is a routine Form 144 filing with minimal market impact expected due to its small size relative to the company's $50.08B market cap. Such sales are common for executive liquidity and compensation purposes.
Comprehensive Analysis
SEC Filing Analysis: Edwards Lifesciences Corp (EW)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of Edwards Lifesciences has filed a notice of intent to sell 2,000 shares, a transaction of minimal financial significance to the company.
- Market Impact: The proposed sale is negligible and is not expected to have any material impact on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | Edwards Lifesciences Corp |
| Ticker Symbol | EW |
| CIK | 0001099800 |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
Insider Information
| Field | Value |
|---|---|
| Name | Chopra Daveen |
| CIK | 0001740963 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-12-11 (Approximate) |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 2,000 |
| Price Per Share | $84.38 (approximate) |
| Total Value | $168,750 |
| Shares Owned After | Not Available |
| Ownership Type | Not Specified |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $168,750 |
| % of Market Cap | 0.00034% |
| Shares Transacted | 2,000 |
| % of Shares Outstanding | 0.00034% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $168,750 proposed sale is insignificant against Edwards Lifesciences' market capitalization of $50.08 billion.
- Transaction Significance: The transaction represents a minuscule fraction of both the market cap and the total shares outstanding, indicating it is a routine event for the insider, likely for personal financial management, rather than a strategic move based on company outlook.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The size of the proposed sale is too small to influence market sentiment or trading dynamics for a large-cap company like Edwards Lifesciences.
Volume & Sentiment
- Expected Volume Impact: Negligible. The 2,000 shares are a tiny fraction of the stock's typical daily trading volume.
- Sentiment Indicator: Neutral. The filing does not provide any new information that would alter investor perception of the company.
Additional Context
Transaction Notes
- This Form 144 is a notice of a proposed sale, not a confirmation that the sale has occurred. It indicates the insider's intent to sell up to the specified number of shares in the near future.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.